Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPPI: Primaquine for Malaria Transmission
NCT02259426Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Oct 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of primaquine in Plasmodium falciparum malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Gametocyte prevalence on day 7 after initiation of treatment. Started Oct 2014; status: completed.
02
Drugs
primaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02259426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259426.